Clicky

Relx PLC ADR(RDED)

Description: RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the events business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.


Keywords: Business Intelligence Analytics Formal Sciences Data Brokers Lexisnexis Risk Solutions Decision Tools Advance Healthcare Elsevier Relx Reed Exhibitions

Home Page: www.relx.com

1-3 Strand
London, WC2N 5JR
United Kingdom
Phone: 44 20 7166 5500


Officers

Name Title
Mr. Erik Engstrom CEO & Exec. Director
Mr. Nicholas Lawrence Luff CFO & Exec. Director
Ms. Kumsal Bayazit Besson Chief Exec. Officer of Scientific, Technical & Medical
Mr. Colin Tennant Head of Investor Relations
Mr. Henry Adam Udow Chief Legal Officer & Company Sec.
Mr. Paul Abrahams Head of Corp. Communications
Ms. Rosemary Thomson Chief HR Officer
Mr. Mark Kelsey Chief Exec. Officer of Risk
Ms. Jelena Sevo Chief Strategy Officer
Mr. Michael Walsh Chief Exec. Officer of Legal

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 20.2429
Trailing PE: 29.011
Price-to-Book MRQ: 12.1642
Price-to-Sales TTM: 6.6124
IPO Date:
Fiscal Year End: December
Full Time Employees: 33000
Back to stocks